General Information of Drug (ID: DM3JURW)

Drug Name
2,6-Diphenyl-pyrimidin-4-ylamine
Synonyms
4-Amino-2,6-diphenylpyrimidine; 2,6-diphenylpyrimidin-4-amine; CHEMBL406788; PLXFRDQUOPPVHF-UHFFFAOYSA-N; 2,6-Diphenyl-4-pyrimidinamine; AC1LDIB7; SCHEMBL1490059; 2,6-Diphenyl-4-pyrimidinamine #; ZINC29062470; BDBM50375487; AKOS011055092; (2,6-diphenyl-pyrimidin-4-yl)-amine
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 247.29
Logarithm of the Partition Coefficient (xlogp) 3.2
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C16H13N3
IUPAC Name
2,6-diphenylpyrimidin-4-amine
Canonical SMILES
C1=CC=C(C=C1)C2=CC(=NC(=N2)C3=CC=CC=C3)N
InChI
InChI=1S/C16H13N3/c17-15-11-14(12-7-3-1-4-8-12)18-16(19-15)13-9-5-2-6-10-13/h1-11H,(H2,17,18,19)
InChIKey
PLXFRDQUOPPVHF-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
619020
TTD ID
D08INY

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Adenosine A1 receptor (ADORA1) TTK25J1 AA1R_HUMAN Inhibitor [1]
Adenosine A2a receptor (ADORA2A) TTM2AOE AA2AR_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines. Bioorg Med Chem. 2008 Mar 15;16(6):2741-52.